Cite
HARVARD Citation
Jin, L. et al. (2022). GSK 650394 Inhibits Osteoclasts Differentiation and Prevents Bone Loss via Promoting the Activities of Antioxidant Enzymes In Vitro and In Vivo. Oxidative medicine and cellular longevity. p. . [Online].